ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,630,000 | -0.2% | 1,000,000 | -20.9% | 7.67% | +14.8% |
| Q2 2023 | $492,423,855 | +2.7% | 1,263,500 | -1.9% | 6.68% | -6.1% |
| Q1 2023 | $479,696,750 | +0.1% | 1,287,500 | +1.7% | 7.11% | -0.7% |
| Q4 2022 | $479,430,201 | +7.3% | 1,265,555 | 0.0% | 7.16% | -13.2% |
| Q3 2022 | $446,804,000 | -6.8% | 1,265,555 | 0.0% | 8.26% | -12.9% |
| Q2 2022 | $479,493,000 | +21.2% | 1,265,555 | +0.8% | 9.48% | +31.2% |
| Q1 2022 | $395,714,000 | +17.1% | 1,255,000 | +30.1% | 7.22% | +25.6% |
| Q4 2021 | $337,933,000 | +18.2% | 965,000 | +2.0% | 5.75% | +28.1% |
| Q3 2021 | $285,843,000 | +0.3% | 946,500 | 0.0% | 4.49% | -9.4% |
| Q2 2021 | $284,963,000 | +11.8% | 946,500 | +2.3% | 4.96% | +12.6% |
| Q1 2021 | $254,873,000 | -4.0% | 925,500 | +2.5% | 4.40% | -3.7% |
| Q4 2020 | $265,416,000 | +12.0% | 902,500 | 0.0% | 4.57% | +35.8% |
| Q3 2020 | $236,924,000 | +8.4% | 902,500 | -7.0% | 3.37% | -22.1% |
| Q2 2020 | $218,473,000 | +77.1% | 970,000 | +3.6% | 4.32% | +3.7% |
| Q1 2020 | $123,365,000 | -17.9% | 936,500 | 0.0% | 4.16% | -5.7% |
| Q4 2019 | $150,327,000 | +58.0% | 936,500 | +12.2% | 4.41% | +11.2% |
| Q3 2019 | $95,157,000 | -20.0% | 835,000 | -0.6% | 3.97% | -3.5% |
| Q2 2019 | $118,927,000 | +13.4% | 840,000 | 0.0% | 4.11% | -9.3% |
| Q1 2019 | $104,866,000 | +26.9% | 840,000 | -2.3% | 4.54% | -8.2% |
| Q4 2018 | $82,620,000 | +44.2% | 860,000 | +13.8% | 4.94% | +87.7% |
| Q3 2018 | $57,291,000 | -11.6% | 755,415 | -3.4% | 2.63% | +5.5% |
| Q2 2018 | $64,801,000 | -6.7% | 782,053 | -9.4% | 2.50% | -24.8% |
| Q1 2018 | $69,442,000 | +36.6% | 863,275 | +7.3% | 3.32% | +0.7% |
| Q4 2017 | $50,820,000 | +423.2% | 804,875 | +87.4% | 3.29% | +337.5% |
| Q3 2017 | $9,713,000 | +112.4% | 429,600 | +99.3% | 0.75% | +30.5% |
| Q2 2017 | $4,573,000 | – | 215,597 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |